The direct inhibition of prostaglandin synthetase of human breast cancer tumor tissue by tamoxifen.
D001859:Bone Neoplasms / Q000556:secondary; D001862:Bone Resorption / Q000187:drug effects; D001943:Breast Neoplasms / Q000150:complications / Q000201:enzymology*; D016861:Cyclooxygenase Inhibitors; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D010014:Osteolysis / Q000209:etiology; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D013237:Stereoisomerism; D013629:Tamoxifen / Q000008:administration & dosage / Q000494:pharmacology*
D016861:Cyclooxygenase Inhibitors; D013629:Tamoxifen; D011451:Prostaglandin-Endoperoxide Synthases; D007213:Indomethacin